Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News
GSK Share
Chat
GSK Share
Trades9,036
GSK
Live RNS
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions1
GSK
Media
GSK Company
Research
GSK Company
Timeline1
Share Price Information for Glaxosmithkline (GSK)
Last checked at -
Last checked at 
Intraday Glaxosmithkline Share Chart
Glaxosmithkline News
LONDON MARKET CLOSE: Traders weigh war deadlock; luxury woes hit Paris
(Alliance News) - The FTSE 100 fell on Wednesday as investors awaited a hoped for resumption in peace talks between the US and Iran.
GSK completes purchase of Canada's 35Pharma for USD950 million
(Alliance News) - GSK PLC on Wednesday said it has completed the acquisition of Canada-based clinical stage biopharmaceutical firm 35Pharma Inc for US...
LONDON BROKER RATINGS: Bernstein cuts Wizz Air and easyJet
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:
GSK ovarian, womb cancer drug posts positive results in early trial
(Sharecast News) - GSK said its gynaecological cancer drug candidate had revealed positive results from early trials and would swiftly move to late-st...
GSK posts encouraging data for endometrial and ovarian cancer drug
(Alliance News) - GSK PLC on Sunday reported positive data for its cancer therapy candidate mocertatug rezetecan.
GSK sees blockbuster potential in targeted cancer therapy after promising early data
* Early data shows GSK's drug helps shrink tumors in hard to treat ovarian and endometrial cancers
LONDON MARKET CLOSE: Oil creeps higher amid fragile US-Iran ceasefire
(Alliance News) - The FTSE 100 nursed modest losses on Thursday as doubts grew over the strength and sustainability of the US-Iran ceasefire.
China approves GSK's Exdensur for treating chronic rhinosinusitis
(Alliance News) - GSK PLC on Wednesday said its Exdensur drug, has been approved in China as an add-on therapy for the treatment of chronic rhinosinus...
Follow the stocks
